Simpson Thacher represented Helio Health Group LLC ("HELIO"), a specialized expert-driven Artificial Intelligence company focused on the life sciences industry, in connection with its strategic minority investment from WestView Capital Partners, a Boston-based growth equity firm.
The investment will provide HELIO with additional capital and strategic support to accelerate its next phase of growth, including expanding its team, deepening its capabilities across life sciences compliance, government pricing, and commercialization sectors, and continuing to invest in AI-enabled platforms that help clients operate more efficiently and intelligently.
HELIO is an expert-driven AI and technology-enabled services firm that helps pharmaceutical, biotechnology, and healthcare companies address complex compliance, government pricing, commercial contracting and operational challenges.
The Simpson Thacher team includes Andy Alin, Daisy Wu and Jeffrey MacDonald (M&A); Andrew Purcell and Adriana De Bartolo (Tax); Gillian Emmett Moldowan and Matthew Behrens (Executive Compensation and Employee Benefits); Caroline Geiger, Anthony Tran and Isabella Gonzalez (Intellectual Property and Data Privacy); Krista McManus (Real Estate); and Vanessa Burrows, Alison Peters and Jake Madden (Healthcare).